Cellular Dynamics International said it has received a patent for a new method of creating stem cells that could open the door to therapeutic research and clinical use. The patent involves using circular pieces of DNA called episomal vectors to reprogram adult tissue cells, such as blood or skin back to a stem cell state. Read the full Milwaukee Journal Sentinel story here.
- Milwaukee Business Journal: Half a billion dollars in VC funds to converge on Madison to hear state startups pitchSeptember 20, 2019
- InsideWis: Turning early stage rejection into ‘yes’ can depend on supply of cashSeptember 19, 2019
- Recovering from business loss is ex-NFL player’s topic Nov. 6 during Early Stage SymposiumSeptember 18, 2019
- Release: WARF investment fund signals new tack in effort to grow adoption of UW–Madison technologiesSeptember 17, 2019
- Investors will meet with emerging companies at 2019 Wisconsin Early Stage SymposiumSeptember 16, 2019